Collaborative AI and Laboratory Medicine integration in precision cardiovascular medicine.
(2020) Clinica Chimica Acta — Vol. 509, p. 67-71 (2020)
Files
2020_Gruson_Clin_Chim_Acta_A.pdf
Abstract
Open Access - Adobe PDF
- 395.94 KB
2020_Gruson_Clin_Chim_Acta.pdf
Restricted Access - Adobe PDF
- 208.78 KB
Details
- Authors
- Abstract
- Artificial Intelligence (AI) is a broad term that combines computation with sophisticated mathematical models and in turn allows the development of complex algorithms which are capable to simulate human intelligence such as problem solving and learning. It is devised to promote a significant paradigm shift in the most diverse areas of medical knowledge. On the other hand, Cardiology is a vast field dealing with diseases relating to the heart, the circulatory system, and includes coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions. AI has emerged as a promising tool in cardiovascular medicine which is aimed in augmenting the effectiveness of the cardiologist and to extend better quality to patients. It has the ability to support decision‑making and improve diagnostic and prognostic performance. Attempt has also been made to explore novel genotypes and phenotypes in existing cardiovascular diseases, improve the quality of patient care, to enablecost-effectiveness with reducereadmissionand mortality rates. Our review addresses the integration of AI and laboratory medicine as an accelerator of personalization care associated with the precision and the need of value creation services in cardiovascular medicine.
- Affiliations
Citations
Gruson, D., Bernardini, S., Dabla, P. K., Gouget, B., & Stankovic, S. (2020). Collaborative AI and Laboratory Medicine integration in precision cardiovascular medicine. Clinica Chimica Acta, 509, 67-71. https://doi.org/10.1016/j.cca.2020.06.001 (Original work published 2020)